NFKB1 and depressive symptom measurement: Pro-anthocyanidin, having potential anti-inflammatory and antioxidative activity efficacy, functions as an effective therapeutic candidate for depression-like behaviors induced by LPS by regulating the NF-κB signal in many cerebral regions and inhibiting the LPS-induced iNOS and the increased expression of COX-2 (46).